Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: a Multicenter Cohort Study

• Prevalence of Venous thromboembolism (VTE) in patients undergoing Hematopoietic Cell Transplant (HCT) at tertiary care pediatric US hospitals is 7%.• Age ≥ 13 years and allogeneic transplants were significant associated risks factor for VTE.• In allogeneic recipients, Graft versus Host Dis ease (GvHD) and infections seen more frequently in patients with VTE.

http://www.bbmt.org/article/S1083-8791(17)30807-8/fulltext?rss=yes

Source: Biology of Blood and Marrow Transplantation - November 8, 2017 Category: Hematology Authors: Hemalatha G. Rangarajan, Joseph R. Stanek, Rolla Abu-Arja, Rajinder P.S. Bajwa, Jeffery J. Auletta, Dean A. Lee, Sarah H.O. Brien, Riten Kumar Source Type: research